patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through
the initial Omicron wave. Methods We conducted a retrospective cohort study investigating
COVID-19 outcomes among patientswith SARD systematically identified to have confirmed
COVID-19 from 1 March 2020 to 31 January 2022 at Mass General Brigham. We tabulated
COVID-19 counts of total and severe cases (hospitalisations or deaths) and compared the …